CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CYP3A5
genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 65, Issue 3, Pages e26854
Publisher
Wiley
Online
2017-11-08
DOI
10.1002/pbc.26854
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
- (2015) Barthelemy Diouf et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Measuring Vincristine-Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
- (2013) Ellen M. Lavoie Smith et al. CANCER NURSING
- Epidemiology of diagnosed childhood cancer in western kenya
- (2012) Saskia Mostert et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention
- (2012) W. Grisold et al. NEURO-ONCOLOGY
- Practical recommendations for the management of children with Endemic Burkitt Lymphoma (BL) in a resource limited setting
- (2012) Peter Hesseling et al. PEDIATRIC BLOOD & CANCER
- The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers
- (2012) Laura S. Gilchrist et al. SUPPORTIVE CARE IN CANCER
- Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group
- (2011) Saskia Mostert et al. LANCET ONCOLOGY
- Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseases
- (2010) Romain Guilhaumou et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Reliability and Validity of a Modified Total Neuropathy Score-Reduced and Neuropathic Pain Severity Items When Used to Measure Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums
- (2010) Ellen M. Lavoie Smith et al. CANCER NURSING
- Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
- (2010) Guido Cavaletti et al. EUROPEAN JOURNAL OF CANCER
- Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties
- (2010) Kathleen A. Griffith et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia
- (2010) Akinbode Egbelakin et al. PEDIATRIC BLOOD & CANCER
- Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia
- (2009) A. Hartman et al. LEUKEMIA RESEARCH
- Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi
- (2009) Trijn Israëls et al. PEDIATRIC BLOOD & CANCER
- Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia
- (2008) Gudmar Lönnerholm et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients
- (2007) Jamie L. Renbarger et al. PEDIATRIC BLOOD & CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started